Pfizer's lung cancer drug shows promising results in long-term trials
CHICAGO— Pfizer On Friday it said its drug for an advanced form of lung cancer showed promising long-term results in…
health care industry
Half of Workers May Have Difficulty Obtaining Obesity Drug Insurance Coverage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Pfizer, Merck and J&J to publish data on cancer drugs
Attendees walk through the lobby of the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Jim Cramer identifies 5 stocks that can be bought here and now
Let's say you just joined the Club and are trying to determine which stocks we think can be bought right…
AI Cancer Detection Is Booming, Most Not Covered by Insurance
Artificial intelligence for cancer detection has taken off. However, most of those new programs are not covered by Medicare or…
Nestlé CEO discusses impact of weight loss drugs on food industry
A photo taken on February 21, 2024 shows the logo of Swiss food giant Nestlé at the company's headquarters in…
Wells Fargo CEO Talks Reasons to Love Stocks, Plus Why the Market is Falling
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Walgreens announces price cuts on 1,300 items amid continued consumer spending fatigue
Signs are seen outside a Walgreens, owned by Walgreens Boots Alliance, Inc., in Manhattan, New York, U.S., November 26, 2021.…
We are increasing our geopolitical coverage and a struggling healthcare stock.
We are expanding our only oil reserve and a disadvantaged medical technology company.
Ro launches GLP-1 supply tracker to help patients overcome shortages
Zoom in iconArrows pointing outwards Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular…